BUZZ-Valeant Pharmaceuticals: CEO Pearson to step down

Mon Mar 21, 2016 9:39am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Canadian drugmaker's U.S. shares up 5 pct at $28.20

** Says CEO Michael Pearson to step down, appoints activist investor William Ackman to board

** Says started a search for a successor to Pearson

** Ackman, whose firm Pershing Square has a 9 pct stake in Valeant, will join Pershing Square's Vice Chairman, Stephen Fraidin, on the board

** "We are committed to filing the 10-K on or before April 29, 2016," Pearson said

** Up to Friday's close, stock had fallen 23 pct this year